Skip to main content

A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson’s disease patients

Abstract

Numerous practice guidelines have recommended cognitive behavioral therapy (CBT) and psychodynamic therapy as a treatment of choice for depression in Parkinson’s disease (PD). However, no recent meta-analysis has examined the effects of brief psychotherapy (which includes both CBT and psychodynamic therapy) for adult depression in PD. We decided to conduct such a systematic review and meta-analysis. We included randomized controlled trials (RCTs) examining the effects of brief psychotherapy compared with control groups, other support nursing, or pharmacotherapy. The quality of included studies was strictly evaluated. Twelve studies including 766 patients met all inclusion criteria. The result showed that brief psychotherapy could evidently improve the HAMD (p < 0.00001) and Moca scale (p = 0.006). There was no statistical significance in PDQ-39 scale (p = 0.31). In the subgroup analysis by types of brief psychotherapy, the efficacy of psychodynamic psychotherapy was better than CBT (SMD = −2.02 vs SMD = −0.90) for the outcome measure according to HAMD scale. Meanwhile, we found brief psychotherapy in China was more effective than in US (SMD = −1.54 vs SMD = −1.23), and in low quality studies was more efficacious than in high quality studies (SMD = −1.50 vs SMD = −1.33). Time of brief psychotherapy treatment above 6 weeks was superior to studies with less than 6 weeks treatment. We found brief psychotherapy is probable effective in the management of depression in PD patients. But one reason to undermine the validity of findings is high clinical heterogeneity and low methodological quality of the included trials.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464–474

    CAS  PubMed  Article  Google Scholar 

  2. Black KJ (2011) A new (old) treatment option for depression in Parkinson’s disease. Am J Psychiatry 168(10):1015–1016

    PubMed  Article  Google Scholar 

  3. Menza M, Dobkin RD, Marin H et al (2009) The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson’s disease. Mov Disord 24(9):1325–1332

    PubMed Central  PubMed  Article  Google Scholar 

  4. Carod-Artal FJ, Ziomkowski S, Mourão Mesquita H et al (2008) Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson’s disease. Parkinsonism Relat Disord 14(2):102–108

    PubMed  Article  Google Scholar 

  5. Aarsland D, Påhlhagen S, Ballard CG et al (2011) Depression in Parkinson disease–epidemiology, mechanisms and management. Nat Rev Neurol 8(1):35–47

    PubMed  Article  Google Scholar 

  6. Menza M, Dobkin RD, Marin H et al (2009) A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72(10):886–892

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  7. Troeung L, Egan SJ, Gasson N (2013) A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease. PLoS One 8(11):e79510

    PubMed Central  PubMed  Article  Google Scholar 

  8. Richard IH, McDermott MP, Kurlan R et al (2012) A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 78(16):1229–1236

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  9. Price A, Rayner L, Okon-Rocha E et al (2011) Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry 82(8):914–923

    PubMed  Article  Google Scholar 

  10. Veazey C, Aki SO, Cook KF et al (2005) Prevalence and treatment of depression in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 17(3):310–323

    PubMed  Article  Google Scholar 

  11. van der Marck MA, Munneke M, Mulleners W et al (2013) Integrated multidisciplinary care in Parkinson’s disease: a non-randomised, controlled trial (IMPACT). Lancet Neurol 12(10):947–956

    PubMed  Article  Google Scholar 

  12. Oehlberg K, Barg FK, Brown GK et al (2008) Attitudes regarding the etiology and treatment of depression in Parkinson’s disease: a qualitative study. J Geriatr Psychiatry Neurol 21(2):123–132

    PubMed Central  PubMed  Article  Google Scholar 

  13. Brewin CR (1996) Theoretical foundations of cognitive-behavior therapy for anxiety and depression. Annu Rev Psychol 47:33–57

    CAS  PubMed  Article  Google Scholar 

  14. Schildmann EK, Higginson IJ (2011) Evaluating psycho-educational interventions for informal carers of patients receiving cancer care or palliative care: strengths and limitations of different study designs. Palliat Med 25(4):345–356

    PubMed  Article  Google Scholar 

  15. Parker B, Turner W (2013) Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused. Cochrane Database Syst Rev 7:CD008162

  16. Dobkin RD, Menza M, Allen LA et al (2011) Cognitive-behavioral therapy for depression in Parkinson’s disease: a randomized, controlled trial. Am J Psychiatry 168(10):1066–1074

    PubMed Central  PubMed  Article  Google Scholar 

  17. Dobkin RD, Menza M, Allen LA et al (2011) Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. J Geriatr Psychiatry Neurol 24(4):206–214

    PubMed Central  PubMed  Article  Google Scholar 

  18. Mohr DC, Ho J, Duffecy J et al (2012) Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA 307(21):2278–2285

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  19. Armento ME, Stanley MA, Marsh L et al (2012) Cognitive behavioral therapy for depression and anxiety in Parkinson’s disease: a clinical review. J Parkinsons Dis. 2(2):135–151

    PubMed  Google Scholar 

  20. Troeung L, Egan SJ, Gasson N (2013) A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease. PLoS One 8(11):e79510

    PubMed Central  PubMed  Article  Google Scholar 

  21. Cuijpers P, van Straten A, Andersson G, van Oppen P (2008) Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 76(6):909–922

    PubMed  Article  Google Scholar 

  22. Kelly JA, Murphy DA, Bahr GR et al (1993) Outcome of cognitive-behavioral and support group brief therapies for depressed. HIV-infected persons. Am J Psychiatry 150(11):1679–1686

    CAS  PubMed  Article  Google Scholar 

  23. Zhang XL, Cui YZ, Yang XS, Yan YX (2007) Efficacy of citalopram and perception treatment in cure of depression induced by Parkinson’s disease. Medical J Chin People Health 19(12):1069–1070

    Google Scholar 

  24. Zhang SF, Wang AX, Luo XP (2008) Efficacy of psychological nursing in cure of depression in 40 case of Parkinson’s disease. Chin J Prac Nerv Dis 11(7):143–145

    Google Scholar 

  25. Veazey C, Cook KF, Stanley M et al (2009) Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson’s disease. J Clin Psychol Med Settings 16(3):243–253

    PubMed  Article  Google Scholar 

  26. Zong YH, Chen NX, Li XP, Fan H (2009) Analysis of psychological therapy for treatment of depressive patients with Parkinson’s disease. China J Health Psychol 17(8):941–943

    Google Scholar 

  27. Deng YD, Ou YF, Wen GQ (2011) Venlafaxine combined with cognitive-behavioral therapy in the treatment of depression in Parklnson’s disease. Hainan Med J 22(17):37–39

    Google Scholar 

  28. Huang Y (2011) Psychological intervention effect on depressive symptoms of depression in patients with Parkinson’s disease. J Modern Nurs 17(17):2049–2051

    Google Scholar 

  29. Mei JH, Shao W, Zhou JF et al (2011) Effects of psychotherapy on depression and cognitive impairment in patients with Parkinson’s disease. Neural Injury Fun Reconstr 6(2):118–122

    Google Scholar 

  30. Chen X, Zhang XW, Zhang YL, Song C (2012) Effect of positive psychological intervention on depression and cognitive impairment in patient with Parkinson’s disease. J Nurs 19(12):64–66

    CAS  Google Scholar 

  31. Chen SY, Ma HX, Chen YE et al (2012) Effect of psychological interview intervention on depression in Parkinson’s disease. Chin J of Gerontology 10(32):4174–4175

    Google Scholar 

  32. Lawson RA, Millar D, Brown RG, Burn DJ (2013) Guided self-help for the management of worry in Parkinson’s disease: a pilot study. J Parkinsons Dis. 3(1):61–68

    PubMed  Google Scholar 

  33. Du ZJ, Chang J, Xie Y (2013) Venlafaxine combined with cognitive-behavioral therapy in the treatment of depression in Parklnson’s disease. Hebei Med J 35(9):1328–1329

    Google Scholar 

  34. Yang S, Sajatovic M, Walter BL (2012) Psychosocial interventions for depression and anxiety in Parkinson’s disease. J Geriatr Psychiatry Neurol 25(2):113–121

    PubMed  Article  Google Scholar 

  35. Gonzalez-Pinto A, Gonzalez C, Enjuto S et al (2004) Psychoeducation and cognitive-behavioral therapy in bipolar disorder: an update. Acta Psychiatr Scand 109(2):83–90

    CAS  PubMed  Article  Google Scholar 

  36. Xie CL, Pan JL, Wang WW et al (2014) The association between the LRRK2 G2385R variant and the risk of Parkinson’s disease: a meta-analysis based on 23 case-control studies. Neurol Sci 35(10):1495–1504

    PubMed  Article  Google Scholar 

  37. Moher D, Pham B, Jones A et al (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352(9128):609–613

    CAS  PubMed  Article  Google Scholar 

  38. Barone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9(6):573–580

    CAS  PubMed  Article  Google Scholar 

  39. Rektorova I, Balaz M, Svatova J et al (2008) Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study. Clin Neuropharmacol 31(5):261–266

    CAS  PubMed  Article  Google Scholar 

  40. Henggeler SW (2004) Decreasing effect sizes for effectiveness studies- implications for the transport of evidence-based treatments: comment on curtis, ronan, and borduin. J Fam Psychol 18(3):420–423

    PubMed  Article  Google Scholar 

  41. Jahoda A, Willner P, Rose J et al (2013) Development of a scale to measure fidelity to manualized group-based cognitive behavioural interventions for people with intellectual disabilities. Res Dev Disabil 34(11):4210–4221

    PubMed  Article  Google Scholar 

  42. Montgomery EC, Kunik ME, Wilson N et al (2010) Can paraprofessionals deliver cognitive-behavioral therapy to treat anxiety and depressive symptoms? Bull Menninger Clin 74(1):45–62

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge Wen–Wen Wang for his help in guiding and revising the manuscript. We also thank all the study participants. The author(s) received no financial support for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wen-Wen Wang.

Additional information

C. Xie and X.-D. Wang contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xie, CL., Wang, XD., Chen, J. et al. A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson’s disease patients. Neurol Sci 36, 833–843 (2015). https://doi.org/10.1007/s10072-015-2118-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2118-0

Keywords

  • Cognitive behavioral therapy
  • Psychosocial treatments
  • Parkinson’s disease
  • Depression
  • Systematic review
  • Meta-analysis